The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression
Published version of a preprint
Abstract
UNLABELLED: B cells often constitute abundant cellular components in human tumors. Regulatory B cells that are functionally defined by their ability to produce IL10 downregulate inflammation and control T-cell immunity. Here, we identified a protumorigenic subset of B cells that constitutively expressed higher levels of programmed cell death-1 (PD-1) and constituted ∼10% of all B cells in advanced-stage hepatocellular carcinoma (HCC). These PD-1(hi) B cells exhibited a unique CD5(hi)CD24(-/+)CD27(hi/+)CD38(dim) phenotype different from the phenotype of conventional CD24(hi)CD38(hi) peripheral regulatory B cells. TLR4-mediated BCL6 upregulation was crucial for PD-1(hi) B-cell induction by HCC environmental factors, and that effect was abolished by IL4-elicited STAT6 phosphorylation. Importantly, upon encountering PD-L1(+) cells or undergoing PD-1 triggering, PD-1(hi) B cells acquired regulatory functions that suppressed tumor-specific T-cell immunity and promoted cancer growth via IL10 signals. Our findings provide significant new insights for human cancer immunosuppression and anticancer therapies regarding PD-1/PD-L1. SIGNIFICANCE: We identify a novel protumorigenic PD-1(hi) B-cell subset in human HCC that exhibits a phenotype distinct from that of peripheral regulatory B cells. TLR4-mediated BCL6 upregulation is critical for induction of PD-1(hi) B cells, which operate via IL10-dependent pathways upon interacting with PD-L1 to cause T-cell dysfunction and foster disease progression. Cancer Discov; 6(5); 546-59. ©2016 AACR.See related commentary by Ren et al., p. 477This article is highlighted in the In This Issue feature, p. 461.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since other cell types (such as dendritic cells and B cells) can also be influenced by PD-1 signaling, inhibition of the PD-1/PD-L1 pathway may also have T cell-independent effects, whose impact on immune responses during checkpoint inhibitor therapy remain to be elucidated (36, 58).”
From Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations (2018) · cites this paper as [58]
Citations
Cites
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114
Follicular Helper CD4 T Cells (T FH )
Crotty, S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101400 · Cited by 2,738
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
Deng, L., Liang, H. L., Burnette, B., Beckett, M., Darga, T. E., Weichselbaum, R. R., & Fu, Y. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67313 · Cited by 2,119
Inhibitory B7-family molecules in the tumour microenvironment
Zou, W., & Chen, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2326 · Cited by 1,608
Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574
Llosa, N. J., Cruise, M., Tam, A., Wicks, E. C., Hechenbleikner, E. M., Taube, J. M., Blosser, R. L., Fan, H., Wang, H., Luber, B. S., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0863 · Cited by 1,487
Innate Immune Pattern Recognition: A Cell Biological Perspective
Brubaker, S. W., Bonham, K. S., Zanoni, I., & Kagan, J. C. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112240 · Cited by 1,475
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 350
Deng, S., Chen, Y., Song, B., Wang, H., Huang, S., Wu, K., & Chu, Q. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01754-7 · Cited by 54
Kono, Y., Saito, H., Miyauchi, W., Shimizu, S., Murakami, Y., Shishido, Y., Miyatani, K., Matsunaga, T., Fukumoto, Y., Nakayama, Y., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-6629-6 · Cited by 48
Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies
Hoseini, S. S., & Cheung, N. V. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.013 · Cited by 47
Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding
Gao, J., Gu, D., Yang, K., Zhang, J., Lin, Q., Yuan, W., Xu, Z., Dixit, D., Gimple, R. C., You, H., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2024.12.006 · Cited by 47
Immunocytes in the tumor microenvironment: recent updates and interconnections
Yu, J., Fu, L., Wu, R., Che, L., Liu, G., Ran, Q., Xia, Z., Liang, X., & Zhao, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1517959 · Cited by 52
Solders, M., Gorchs, L., Gidlöf, S. B., Tiblad, E., Lundell, A., & Kaipe, H. (2017) · Stem Cells International · doi:10.1155/2017/8010961 · Cited by 47
B cell heterogeneity, plasticity, and functional diversity in cancer microenvironments
Yuan, W., Huang, C.-X., Xiao, C., Chen, D., Shan, H., He, H., & Kuang, D. (2021) · Oncogene · doi:10.1038/s41388-021-01918-y · Cited by 46
Self-citationImpact of immune cells on the hallmarks of cancer: A literature review
Costa, A. C., Santos, J., da Costa, R. M. G., & Medeiros, R. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103541 · Cited by 48
Personalized treatment for hepatocellular carcinoma: Current status and future perspectives
Chan, S. L., Wong, N., Lam, W. K., & Kuang, M. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15889 · Cited by 44
B cells as biomarkers: predicting immune checkpoint therapy adverse events
Liudahl, S. M., & Coussens, L. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99036 · Cited by 46
Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
Cho, H. J., & Cheong, J. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158011 · Cited by 51
Characterization of Organ-Specific Regulatory B Cells Using Single-Cell RNA Sequencing
Yang, S.-Y., Long, J., Huang, M.-X., Luo, P., Bian, Z.-H., Xu, Y.-F., Wang, C., Yang, S., Li, L., Selmi, C. F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.711980 · Cited by 46
Ouyang, T., Kan, X., & Zheng, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.898964 · Cited by 43
Playoust, E., Remark, R., Vivier, É., & Milpied, P. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01060-7 · Cited by 44
Kim, M. J., & Ha, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.767466 · Cited by 46
Activated B cells suppress T-cell function through metabolic competition
Imahashi, N., Başar, R., Huang, Y., Wang, F., Baran, N., Banerjee, P. P., Lu, J., Cortes, A. K. N., Uprety, N., Ensley, E. L., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005644 · Cited by 42
Characterization of intratumoral and circulating IL-10-producing B cells in gastric cancer
Hu, H., Ai, X., Lu, M., Song, Z., & Li, H.-L. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111652 · Cited by 46
B cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis
Zeng, Q., Yuan, W., Lao, X., Chen, D., Huang, C.-X., Lin, Q., He, M. Y., Liao, Y., Zheng, L., Li, B., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb6296 · Cited by 45
Self-citationSTINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development
Filderman, J. N., Appleman, M., Chelvanambi, M., Taylor, J. L., & Storkus, W. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690105 · Cited by 42
Metabolites and Immune Response in Tumor Microenvironments
Cortellino, S., & Longo, V. D. (2023) · Cancers · doi:10.3390/cancers15153898 · Cited by 43
PD ‐1 is highly expressed by neoplastic B‐cells in Richter transformation
Behdad, A., Griffin, B. B., Chen, Y., Ma, S., Kelemen, K., Lu, X., & Chen, Q. C. (2018) · British Journal of Haematology · doi:10.1111/bjh.15514 · Cited by 41
Han, J. W., & Yoon, S. K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091387 · Cited by 40
Jia, L., Wang, T., Zhao, Y., Zhang, S., Ba, T., Kuai, X., Wang, B., Zhang, N., Zhao, W., Yang, Z., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1969767 · Cited by 42
Flores‐Borja, F., & Blair, P. A. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac029 · Cited by 43
Ye, L., Li, Y., Tang, H., Liu, W., Chen, Y., Dai, T., Liang, R., Shi, M., Yi, S., Chen, G., et al. (2019) · Aging · doi:10.18632/aging.102308 · Cited by 39
PD-1 Shapes B Cells as Evildoers in the Tumor Microenvironment
Ren, Z., Peng, H., & Fu, Y. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0307 · Cited by 38
Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity
Qin, Y., Lu, F., Lyu, K., Chang, A. E., & Li, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.881427 · Cited by 40
Zhao, M., Huang, H., He, F., & Fu, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1188277 · Cited by 40
Circulating Exosomes Inhibit B Cell Proliferation and Activity
Schroeder, J. C., Puntigam, L. K., Hofmann, L., Jeske, S. S., Beccard, I. J., Doescher, J., Laban, S. A., Hoffmann, T. K., Brunner, C., Theodoraki, M., et al. (2020) · Cancers · doi:10.3390/cancers12082110 · Cited by 40
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanomaPreprint
Griss, J., Bauer, W. M., Wagner, C., Maurer‐Granofszky, M., Simon, M., Chen, M., Steinberger, P., Grabmeier‐Pfistershammer, K., Roka, F., Penz, T., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/478735 · Cited by 37
Self-citationYang, H., Zhang, Z., Li, J., Wang, K., Zhu, W., & Zeng, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111825 · Cited by 43
Novel Frontiers in Regulatory B cells
Mauri, C. (2021) · Immunological Reviews · doi:10.1111/imr.12964 · Cited by 38
Liu, M., Sun, Q., Wang, J., Wei, F., Yang, L., & Ren, X. (2018) · International Journal of Cancer · doi:10.1002/ijc.31850 · Cited by 34
Zhang, C., Rong, H.-M., Li, T., Zhai, K., & Tong, Z.-H. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0234oc · Cited by 34
Bao, J., Betzler, A. C., Heß, J., & Brunner, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1233085 · Cited by 35
Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells
Do, P., Beckwith, K. A., Cheney, C. M., Tran, M., Beaver, L. P., Griffin, B. G., Mo, X. M., Liu, Y., Lapalombella, R., Hertlein, E. K., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801359 · Cited by 33
Metabolic guidance and stress in tumors modulate antigen-presenting cells
Park, J., Wang, L., & Ho, P. (2022) · Oncogenesis · doi:10.1038/s41389-022-00438-y · Cited by 33
Tumor-infiltrating B cells: Their dual mechanistic roles in the tumor microenvironment
Xue, D., Hu, S., Zheng, R., Luo, H., & Ren, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117436 · Cited by 36
Current Perspectives on B Lymphocytes in the Immunobiology of Hepatocellular Carcinoma
Qin, M., Wang, D., Fang, Y., Zheng, Z., Liu, X., Wu, F., Wang, L., Li, X., Hui, B., Ma, S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.647854 · Cited by 32
Self-citationCellular based immunotherapy for primary liver cancer
Zheng, Y., Li, Y., Feng, J., Li, J., Ji, J., Wu, L., Yu, Q., Dai, W., Wu, J., Zhou, Y., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02030-5 · Cited by 32
Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma
Zhou, Z., Wang, Z., Gao, J., Lin, Z., Wang, Y., Shan, P., Li, M., Zhou, T., & Li, P. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.03.002 · Cited by 33
Lin, C.-H., Elkholy, K. H., Wani, N. A., Ding, L., Hu, P., Barajas, J. M., Yu, L., Zhang, X., Jacob, S. T., Khan, W. N., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0135 · Cited by 31
Nakahara, Y., Matsutani, T., Igarashi, Y., Matsuo, N., Himuro, H., Saito, H., Yamada, K., Murotani, K., Hoshino, T., Azuma, K., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02900-z · Cited by 30
The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas
Garcia-Lacarte, M., Grijalba, S. C., Melchor, J., Arnaiz-Leché, A., & Roa, S. (2021) · Cancers · doi:10.3390/cancers13184683 · Cited by 32
Papadakos, S. P., Arvanitakis, K., Stergiou, I. Ε., Lekakis, V., Davakis, S., Christodoulou, M., Germanidis, G. S., & Theocharis, S. E. (2023) · Cancers · doi:10.3390/cancers15102795 · Cited by 31
IL-27-containing exosomes secreted by innate B-1a cells suppress and ameliorate uveitis
Kang, M., Yadav, M. K., Mbanefo, E. C., Yu, C., & Egwuagu, C. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1071162 · Cited by 28
B Cell Regulation in Autoimmune Diseases
Av, S., Shmidt, A. A., & Lomakin, Y. A. (2018) · Acta Naturae · doi:10.32607/20758251-2018-10-3-11-22 · Cited by 28
Suppressive mechanisms of regulatory B cells in mice and humans
Matsumura, Y., Watanabe, R., & Fujimoto, M. (2022) · International Immunology · doi:10.1093/intimm/dxac048 · Cited by 29
Small-molecule-based targeted therapy in liver cancer
Ming, Y., Gong, Y., Fu, X., Ouyang, X., Peng, Y., & Pu, W. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.08.001 · Cited by 27
Ahsan, N. F., Lourenco, S. F., Psyllou, D., Long, A. P., Shankar, S., & Bashford-Rogers, R. J. M. (2024) · Oxford Open Immunology · doi:10.1093/oxfimm/iqae012 · Cited by 29
A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications
Knox, M. C., Ni, J., Bece, A., Bucci, J. A., Chin, Y. S., Graham, P., & Li, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01612 · Cited by 29
Golonka, R. M., & Vijay–Kumar, M. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.10.004 · Cited by 28
Upregulation of PD-1 Expression and High sPD-L1 Levels Associated with COVID-19 Severity
Beserra, D. R., Alberca, R. W., Branco, A. C. C. C., Oliveira, L. D. M., Andrade, M. M. D. S., Gozzi-Silva, S. C., Teixeira, F. M. E., Yendo, T. M., Duarte, A. J. D. S., & Sato, M. N. (2022) · Journal of Immunology Research · doi:10.1155/2022/9764002 · Cited by 30
Wang, X., Li, J., Lu, C., Wang, G., Wang, Z., Liu, X., Liu, B., Wang, G., Zhang, Q., & Yang, Q. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.01.021 · Cited by 26
Role of regulatory B cells in gastric cancer: Latest evidence and therapeutics strategies
Jing, Y., Xu, F., Liang, W., Liu, J., & Zhang, L. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107581 · Cited by 27
Li, X., Du, H., Zhan, S., Liu, W., Wang, Z., Lan, J. Q., PuYang, L., Wan, Y., Qu, Q., Wang, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.830606 · Cited by 26
Self-citationStrategies for improving the efficacy of immunotherapy in hepatocellular carcinoma
Zhu, Y., & Qin, L. (2022) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2022.08.003 · Cited by 26
Immune Checkpoints in B Cells: Unlocking New Potentials in Cancer Treatment
Shi, X., Cheng, X., Jiang, A., Shi, W., Zhu, L., Mou, W., Glaviano, A., Liu, Z., Cheng, Q., Lin, A., et al. (2024) · Advanced Science · doi:10.1002/advs.202403423 · Cited by 25
PLAN B for immunotherapy: Promoting and leveraging anti-tumor B cell immunity
Shi, Y. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.028 · Cited by 25
Wang, Y.-M., Qiu, J.-J., Qu, X.-Y., Peng, J., Lu, C., Zhang, M., Zhang, M.-X., Qi, X.-L., Lv, B., Guo, J.-J., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2034257 · Cited by 30
Shi, J., Zhu, X., & Yang, J.-B. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i1.102273 · Cited by 24
Gao, D., Kan, P., He, Y., Sun, S., Tang, L., & Yang, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1656733 · Cited by 25
PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma
Jiang, F., Yu, W., Zeng, F., Cheng, G., Xu, J., Yang, S., Shui, Y., Wu, D., Xiao-fang, Y., & Wei, Q. (2019) · BMC Cancer · doi:10.1186/s12885-019-5689-y · Cited by 24
Cervera-Carrascón, V., Quixabeira, D. C. A., Santos, J. M., Havunen, R., Milenova, I. E., Verhoeff, J., Heiniö, C., Zafar, S., García-Vallejo, J. J., van Beusechem, V. W., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.706517 · Cited by 24
Unraveling the role of Breg cells in digestive tract cancer and infectious immunity
Moreira, H., Dobosz, A., Cwynar-Zając, Ł., Nowak, P., Czyżewski, M., Barg, M., Reichert, P., Królikowska, A., & Barg, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.981847 · Cited by 24
The role of immune regulation in HBV infection and hepatocellular carcinogenesis
Zheng, H., Xu, B., Fan, Y., Tuekprakhon, A., Stamataki, Z., & Wang, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1506526 · Cited by 26
PD-1 blockade augments humoral immunity through ICOS-mediated CD4+ T cell instruction
Zhang, M., Xia, L., Yang, Y., Liu, S., Ji, P., Wang, S., Chen, Y., Liu, Z., Zhang, Y., Lü, S., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.045 · Cited by 23
Classical Hodgkin’s Lymphoma in the Era of Immune Checkpoint Inhibition
Re, V. D., Caggiari, L., Repetto, O., Mussolin, L., & Mascarin, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101596 · Cited by 23
B cells in tumor metastasis: friend or foe?
Xu, Y., Mao, Y., Lv, Y., Tang, W., & Xu, J. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79482 · Cited by 23
Exosomal miRNAs and breast cancer: a complex theranostics interlink with clinical significance
Mukherjee, S., Dhar, R., Jonnalagadda, S., Gorai, S., Nag, S., Kar, R., Mukerjee, N., Mukherjee, D., Vatsa, R., Devi, A., et al. (2023) · Biomarkers · doi:10.1080/1354750x.2023.2229537 · Cited by 24
Knock-Down of CD24 in Astrocytes Aggravates Oxyhemoglobin-Induced Hippocampal Neuron Impairment
Chen, X.-X., Tao, T., Gao, S., Wang, H., Zhou, X., Gao, Y., Hang, C., & Li, W. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03468-x · Cited by 22
Augé, H., Notarantonio, A., Morizot, R., Quinquenel, A., Fornecker, L., Hergalant, S., Feugier, P., & Broséus, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594841 · Cited by 23
The Role of B Cells in Head and Neck Cancer
Gavrielatou, N., Vathiotis, I. A., Economopoulou, P., & Psyrri, A. K. (2021) · Cancers · doi:10.3390/cancers13215383 · Cited by 21
Repáraz, D., Aparicio, B., Llópiz, D., Hervás‐Stubbs, S., & Sarobe, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042022 · Cited by 24
Wu, I., Wu, Y., Yang, H., Hsu, C.-K., Chang, L., Twu, Y., Chang, Y., Chung, W., Yang, C.-W., Hsieh, W., et al. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac196 · Cited by 21
Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies
Maher, N., Mouhssine, S., Matti, B. F., Alwan, A., & Gaïdano, G. (2025) · Cancers · doi:10.3390/cancers17050907 · Cited by 22
Huang, T., Zhang, Q., Yi, J., Wang, R., Zhang, Z., Luo, P., Zeng, R., Wang, Y., & Tu, M. (2023) · Small · doi:10.1002/smll.202301749 · Cited by 20
Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma
Li, T., Jiao, J., Ke, H., Ouyang, W., Wang, L., Pan, J., & Li, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1200201 · Cited by 21
Self-citationNon-canonical PD-1 signaling in cancer and its potential implications in clinic
Zha, H., Jiang, Y., Wang, X., Shang, J., Wang, N., Yu, L., Zhao, W., Li, Z., Zhang, X., Zhang, X., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001230 · Cited by 24
Argemí, J., Ponz‐Sarvisé, M., & Sangro, B. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2022.03.002 · Cited by 19
Deep immune B and plasma cell repertoire in non-small cell lung cancer
Patel, A. J., Khan, N., Richter, A. G., Naidu, B. V., Drayson, M. T., & Middleton, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1198665 · Cited by 20
Yang, C., Zhang, Y., Wang, R. Y., Cheng, B., Wu, Y., & Fu, X. (2023) · Autoimmunity · doi:10.1080/08916934.2023.2290909 · Cited by 19
Huang, Q., Zhong, X., Li, J., Hu, R., Yi, J., Sun, J., Xu, Y., & Zhou, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116409 · Cited by 19
Diversity of regulatory B cells: Markers and functions
Bradford, H. F., & Mauri, C. (2024) · European Journal of Immunology · doi:10.1002/eji.202350496 · Cited by 21
MiR‐15a/16‐1 deficiency induces IL‐10‐producing CD19+ TIM‐1+ cells in tumor microenvironment
Jia, X., Liu, H., Xu, C. B., Han, S., Shen, Y., Miao, X., Hu, X., Lin, Z., Li, Q., Wang, Z., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14037 · Cited by 19
Ethanol extract of Ophiorrhiza pumila suppresses liver cancer cell proliferation and migration
Liu, H., Liao, W., Fan, L., Zheng, Z., Liu, D., Zhang, Q., Yang, A., & Liu, F. (2020) · Chinese Medicine · doi:10.1186/s13020-020-0291-4 · Cited by 19
Zahran, A. M., Hetta, . F., Rayan, A., Eldin, A. S., Hassan, E. A., Fakhry, H., Soliman, A. S. A., & El‐Badawy, O. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02465-y · Cited by 19
Jin, Y., Yu, G., Hu, P., Yang, C., Li, X., Chen, X., Wei, Q., & Wang, J. (2020) · Immunologic Research · doi:10.1007/s12026-020-09155-3 · Cited by 23
Self-citationTargeting Neoepitopes to Treat Solid Malignancies: Immunosurgery
de Sousa, E., Lérias, J. R., Antonio Lopez-beltran, B., Paraschoudi, G., Condeço, C., Kamiki, J., António, P., Figueiredo, N., Carvalho, C. T., Castillo-Martín, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.592031 · Cited by 17
Hung, Y., Shao, Y., Lee, J., Hsu, C., Hsu, C., Yang, M., & Chao, Y. (2021) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000477 · Cited by 18
Galasso, L., Cerrito, L., Maccauro, V., Termite, F., Ainora, M. E., Gasbarrini, A., & Zocco, M. A. (2024) · Cancers · doi:10.3390/cancers16101837 · Cited by 18
Zhou, Z., Chen, J., Zhang, R., Ye, L., Wang, J., Pan, Y., Wang, X., Li, W., Zhang, Y., Xu, L., et al. (2020) · 癌症：英文版 · doi:10.1002/cac2.12069 · Cited by 16
Self-citationVitale, M., Scialò, F., Passariello, M., Leggiero, E., D'Agostino, A. G., Tripodi, L., Gentile, L., Bianco, A., Castaldo, G., Cerullo, V., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.902190 · Cited by 17
Cutmore, L. C., Brown, N. F., Raj, D., Chauduri, S., Wang, P., Maher, J. F., Wang, Y., Lemoine, N. R., & Marshall, J. F. (2020) · Pancreatology · doi:10.1016/j.pan.2020.02.006 · Cited by 18
Tao, P., Hong, L., Tang, W., Lü, Q., Zhao, Y., Zhang, S., Ma, L., & Xue, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.574778 · Cited by 17
Gao, F., Xie, K., Xiang, Q., Qin, Y., Chen, P., Wan, H., Deng, Y., Huang, J., & Wu, H. M. (2021) · Aging · doi:10.18632/aging.202710 · Cited by 18
Milardi, G., & Lleò, A. (2023) · Cancers · doi:10.3390/cancers15072182 · Cited by 16
Regulatory B Cells: Key Players in Hepatocellular Carcinoma Progression
Hetta, H., Elkady, A., Tohamy, T. A., & Badary, M. (2016) · Gastroenterology & Hepatology Open Access · doi:10.15406/ghoa.2016.05.00136 · Cited by 19
PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma
Curran, C. S., & Sharon, E. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.12.001 · Cited by 17
Sørensen, A. L., Bjørn, M. E., Riley, C. H., Holmström, M. O., Andersen, M. H., Svane, I. M., Mikkelsen, S. U., Skov, V., Kjær, L., Hasselbalch, H. C., et al. (2019) · European Journal Of Haematology · doi:10.1111/ejh.13292 · Cited by 16
Metadata
- Authors
- Xiao, X., Lao, X.-M., Chen, M.-M., Liu, R.-X., Wei, Y., Ouyang, F.-Z., Chen, D.-P., Zhao, X.-Y., Zhao, Q., Li, X.-F., Liu, C.-L., Zheng, L., & Kuang, D.-M.
- Affiliations
- 1Key Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
- Sun Yat-sen University Cancer Center (CN)
- Sun Yat-sen University (CN)
- Venue
- Cancer Discovery
- Published
- 2016-05-01
- Volume
- 6
- Issue
- 5
- Pages
- 546-559
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W2295125580
- Cited by
- 352
- References
- 46
- Citations by year
- 2026: 23 · 2025: 42 · 2024: 37 · 2023: 35 · 2022: 46 · 2021: 57 · 2020: 35 · 2019: 34 · 2018: 20 · 2017: 13 · 2016: 10
- FWCI
- 15.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81422036, 31470855, 81171982)
- Guangdong Natural Science Funds for Distinguished Young Scholars (S2013050014639)
- Doctoral Dissertation of PR China (201230)
- Fundamental Research Funds for the Central Universities (15lgjc09)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- regulatory B cells, hepatocellular carcinoma, PD-L1, TLR4, BCL6, IL-10, STAT6, tumor immunosuppression, T cell suppression, B-cell phenotype, cancer immunotherapy
- MeSH terms
- Animals, Disease Models, Animal, Flow Cytometry, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Neoplasm Staging, Phenotype, Protein Binding, Recurrence, Signal Transduction, Biomarkers, Gene Expression, Immunophenotyping, Cytokines, Lymphocytes, Tumor-Infiltrating, Disease Progression, Cell Line, Tumor, STAT6 Transcription Factor, Mice, Proto-Oncogene Proteins c-bcl-6, Immunomodulation, B-Lymphocytes, Regulatory, B7-H1 Antigen, Programmed Cell Death 1 Receptor, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
